Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapy

Thirty-six patients with locally advanced breast cancer received diethylstilbestrol (1 mg/die) for 3 days followed by FAC (5 Fu 600 mg/m2, adriamycin 50 mg/m2, cytoxan 600 mg/m2) on day 4, q. 21 days. After three cycles, responsive patients were submitted to surgery. Tumor kinetic parameters were evaluated by TLI and PDP-LI in 22 patients on serial tumor biopsies at diagnosis (TO), after DES (T1), 24 hrs after the first FAC (T2) and at the time of radical surgery (T3). An estrogenic recruitment was evident by TLI in 9/22 tumors and by PDP-LI in 16/22 patients. Our results demonstrate that diethylstilbestrol can induce a kinetic recruitment of breast cancer cells independently from their ER content and that chemotherapy is able to stop cell proliferation.     

Performance of anaerobic baffled reactor (ABR) treating synthetic wastewater containing p-nitrophenol

In this study, the effect of increasing p-nitrophenol (PNP) concentrations on the performance of anaerobic baffled reactor (ABR) (chemical oxygen demand (COD), removals, volatile fatty acid (VFA), p-aminophenol (PAP) and methane gas productions) was investigated through 240 days. The PNP concentrations were raised to 700 from 10 mg/L corresponding to PNP loading rates of 0.97 and 67.9 g/m³ day. The PNP and COD removal efficiencies were 99 and 90% at PNP loading rates as high as 33.9 g/m³ day, respectively, through the acclimation of anaerobic granular sludge. After this loading rate, the removal efficiencies decreased to 79%. The COD removal efficiencies were high in compartment 1 (E = 78–93%) while a small amount of COD removal was achieved in compartments 2 and 3. The PNP removal efficiencies were approximately 90% in all PNP loading rates except for loading rate of 0.97 g/m³ day. The maximum PNP removal efficiency was measured as 99% at a loading rate of 8.32 g/m³ day. The optimum PNP loading rate for maximum COD, PNP removals and methane yield was 8.32 g/m³ day. The total, methane gas productions and methane percentages were approximately 2160–2400 mL/day and 950–1250 mL/day and 44–52% for the PNP loading rates varying between 4.36 and 33.9 g/m³ day, respectively. For PNP loading rates varying between 33.9 and 67.9 g/m³ day, the total, methane gas productions and methane percentages were approximately 2160 and 960 mL/day and 44%, respectively. The highest total volatile fatty acid (TVFA) concentrations were found in the first compartment with fluctuated values varied between 50 and 200 mg/L indicating the acidogenesis. p-Aminophenol was found as the main intermediate through anaerobic degradation of PNP which later was broken down to phenol and ammonia.     

苦参碱对大鼠乳腺癌细胞荷瘤生长及其炎性因子与免疫功能的影响

目的：探讨苦参碱对大鼠乳腺癌细胞荷瘤大鼠生长及其炎性因子与免疫功能的影响。方法：雌性Wistar大鼠60只,随机分为对照组（n=10）,乳腺癌细胞荷瘤大鼠建模组（n=50）。建模大鼠再随机分为5组（n=10）：模型组、苦参碱低（50 mg/kg）、中（100 mg/kg）、高（200 mg/kg）剂量组和香菇多糖（200 mg/kg）组。除对照组外,每只大鼠右腋皮下接种0.4 ml Walker 256乳腺癌细胞悬液（5×10⁷ cells/ml）。按10 ml/kg的体积腹腔注射给药,2次/日,连续14 d。14 d后麻醉大鼠,腹主动脉取血,取瘤组织称取质量,计算抑瘤率;检测大鼠外周血IL-2、IFN-γ、IL-6、IL-10、TGF-β、CD3⁺、CD4⁺、CD8⁺、IgG、IgM、IgA水平。结果：苦参碱低、中、高剂量组和香菇多糖组大鼠瘤块平均质量分别为（4.99±0.93）g、（4.52±0.92）g、（4.22±1.18）g、（4.52±0.92）g,与模型组（6.62±1.20）g比较均明显降低（P<0.01）。苦参碱各剂量组与香菇多糖组比较,瘤块平均质量无明显差异（P>0.05）。苦参碱低、中、高剂量组和香菇多糖组抑瘤率分别为24.6%、31.7%、36.3%和27.9%,组间无统计学差异。模型组大鼠IL-2、IFN-γ、CD8⁺较对照组明显降低（P<0.01）;而IL-6、IL-10、TGF-β、CD3⁺、CD4⁺、IgG、IgM、IgA较对照组明显升高（P<0.01）。苦参碱低、中、高剂量组和香菇多糖组IL-2、IFN-γ、CD8+较模型组显著升高（P<0.01,P<0.05）;而IL-6、IL-10、TGF-β、CD3⁺、CD4⁺、IgG、IgM、IgA较模型组明显降低（P<0.01,P<0.05）。与香菇多糖组比较,苦参碱低、中剂量组IgM、IgA明显升高（P<0.01,P<0.05）;高剂量组IL-2和IFN-γ、IgA水平明显升高（P<0.01,P<0.05）;低剂量组IFN-γ水平明显降低（P<0.05）;高剂量组IL-10、CD4⁺水平明显降低（P<0.01,P<0.05）。结论：苦参碱具有明显的抑制肿瘤生长的作用,其抑瘤机制与其提高细胞和体液免疫、减轻炎症反应有关。     

The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer

As part of a clinical study designed to modulate oestrogen and progestogen receptor (ER and PR) binding site concentrations prior to chemotherapy ER and PR levels have been estimated immediately before treatment, after ethynyloestradiol (EE, 10 micrograms/day, 1 week) and after medroxyprogesterone acetate (MPA, 500 mg/day i.m., 2 weeks) in tumour tissue from 14 women with advanced breast cancer. There was no consistent change after EE treatment. MPA tended to decrease ER and PR levels, though some increases were also seen. Responses (10 complete and 3 partial remissions) to sequential cyclical hormono-chemotherapy were not related to ER or PR levels prior to chemotherapy.     

Exemestane experience in breast cancer treatment

Exemestane is a very potent, orally active, selective and long-lasting steroidal irreversible inhibitor of aromatase. It is 150 times more potent than aminoglutethimide (AG) in inhibiting human placental aromatase (K_i of 4.3 and 671 nM, respectively). The compound is presently under phase III evaluation in Europe and the U.S.A. for the treatment of postmenopausal advanced breast cancer (ABC). Clinical pharmacology studies have been carried out with single doses ranging from 0.5 to 800 mg and repeated doses of up to 600 mg a day, in 132 postmenopausal healthy volunteers and in 185 post-menopausal women with ABC. Results obtained using a very specific and sensitive analytical method (high performance liquid chromatography—radioimmunoassay; HPLC—RIA) indicated that exemestane is extremely effective in inhibiting plasma estrogens levels. Estrogen inhibition is clearly evident at 5 mg a day and maximal suppression for E₂, E₁ and E₁S (>85%, >90% and>90%, respectively) is obtained at 10–25 mg a day. Data from non-controlled phase II studies involving more than 400 patients indicated a clear anti-tumour activity in postmenopausal ABC patients failing multiple hormonal treatments. In 62 patients progressing on AG (≥500 mg a day) exemestane treatment resulted in an objective response rate of approximately 24%; disease stabilization ≥24 weeks was observed in an additional 24% of cases. With regard to safety, although daily doses up to 600 mg were administered, the maximal tolerated dose was not achieved; reported symptoms were mainly related to the pharmacological action of the compound and were usually mild to moderate in severity, resulting in the discontinuation of therapy in less than 3% of cases. In conclusion, the available results suggest that exemestane treatment is associated with minimal toxicity, and may be of significant benefit for ABC women who have exhausted conventional therapy.     

Effect of lignans isolated from Hernandia nymphaeifolia on estrogenic compounds-induced calcium mobilization in human neutrophils

The effect of five lignans isolated from Hernandia nymphaeifolia on estrogenic compounds (17β-estradiol, tamoxifen and clomiphene)-induced Ca²⁺ mobilization in human neutrophils was investigated. The five lignans were epi-yangambin, epi-magnolin, epi-aschantin, deoxypodophyllotoxin and yatein. In Ca²⁺–containing medium, the lignans (50–100 μM) inhibited 10 μM 17β-estradiol- and 5 μM tamoxifen-induced increases in intracellular free Ca²⁺ levels ([Ca²⁺]_i) without changing 25 μM clomiphene-induced [Ca²⁺]_i increase. 17β-estradiol and tamoxifen increased [Ca²⁺]_i by causing Ca²⁺ influx and Ca²⁺ release because their responses were partly reduced by removing extracellular Ca²⁺. In contrast, clomiphene solely induced Ca²⁺ release. The effect of the lignans on these two Ca²⁺ movement pathways underlying 17β-estradiol- and tamoxifen-induced [Ca²⁺]_i increases was explored. All the lignans (50–100 μM) inhibited 10 μM 17β-estradiol-and 5 μM tamoxifen-induced Ca²⁺ release, and 17β-estradiol-induced Ca²⁺ influx. However, only 100 μM epi-aschantin was able to reduce tamoxifen-induced Ca²⁺ influx while the other lignans had no effect. Collectively, this study shows that the lignans altered estrogenic compounds-induced Ca²⁺ signaling in human neutrophils in a multiple manner.     

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

Analysis of EGFr and ER was performed on tumour samples from 231 patients with operable breast cancer followed for up to 6 yr after surgery. The median duration of follow-up in patients still alive at the time of analysis was 45 months.

Thirty-five percent of patients (82) had tumours greater than 10 fmol/mg ¹²⁵I-EGF binding (EGFr⁺) and 47% (109) had cystolic ER concentration >5 fmol/mg (ER⁺), with a marked inverse relationship between EGFr and ER (P<0.00001). EGFr was second only to axillary node status as a prognostic marker for all patients both in terms of relapse-free and overall survival (P<0.001, logrank EGFr⁺ vs EGFr⁻).

For patients with histologically negative axillary nodes EGFr was superior to ER in predicting relapse and survival (P<0.01 and P<0.005, respectively, compared to P<0.1 and P<0.1, logrank). In a multivariate (Cox model) analysis only EGFr, out of EGFr, ER, size and grade, was predictive for either relapse-free or overall survival for patients with node-negative disease (P=0.052 and P=0.026, respectively).

The correlation of neu expression with response to tamoxifen in patients with recurrent disease was assessed immunochemically. Response rate was reduced in the presence of neu from 50 to 17% for ER⁺ cases and from 26 to 0% for ER⁻ cases.     

氰氟虫腙对草地贪夜蛾的毒力与田间防效

【目的】本研究旨在明确氰氟虫腙对草地贪夜蛾Spodoptera frugiperda幼虫的毒力水平和田间防治效果,为科学使用氰氟虫腙防治草地贪夜蛾提供参考依据。【方法】采用饲料混毒法在室内测定了氰氟虫腙与4种常用杀虫剂甲维盐、氯虫苯甲酰胺、虱螨脲和茚虫威对草地贪夜蛾3和6龄幼虫的致死中浓度(LC₅₀)及LC₉₀值,以及LC₉₀浓度的这些杀虫剂对3龄幼虫的致死中时(medium lethal time, LT₅₀)值。采用人工喷雾方法测定了玉米田中22%氰氟虫腙悬浮剂(6.6 g/667 m²)、22%氰氟虫腙悬浮剂(17.6 g/667 m²)、5.7%甲维盐水分散剂(1 g/667 m²)和150 g/L茚虫威悬浮剂(2 g/667 m²)对草地贪夜蛾幼虫的防效。【结果】室内生测结果显示,供试的5种杀虫剂中氰氟虫腙对草地贪夜蛾3和6龄幼虫均具有较高的毒力,其LC₅₀值分别为2.64和4.3...     

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update

OBJECTIVE: A previous phase-2 trial to assess the addition of Endostar to gemcitabine and cisplatin (GC) chemotherapy showed that it improves prognosis in metastatic nasopharyngeal carcinoma (M-NPC) but the study cohort was small. We wished to update that phase-2 trial by enrolling an additional 44 patients and to assess the benefit of Endostar+GC chemotherapy. METHODS: An analysis of 72 M-NPC patients treated between July 2010 and November 2016 was done. The treatment regimen was a combination of gemcitabine (1,000 mg/m²) on days 1 and 8, cisplatin (80 mg/m²) on day 1, and Endostar (15 mg/day) from day 1 to day 14 of a 21-day cycle for ≥2 cycles. The acute toxic effects and therapeutic efficacy were analyzed. RESULTS: The response rate was 77.8%. The median progression-free and overall survivals were 12 and 19.5 months, respectively. A total of 329 cycles of GC and 288 cycles of Endostar were delivered to 72 patients, with the median number of four (range, 2–10) cycles administered per patient. The main grade-3/4 hematologic toxicities were leukopenia (54.1%) and neutropenia (59.8%). The number of non-hematologic adverse events was minimal. The regimen was well-tolerated. CONCLUSIONS: Endostar+GC chemotherapy is an effective, well-tolerated regimen for M-NPC.     

Biotreatment of swine manure by intensive lagooning during winter

The intent of the proposed system was to develop an in situ biotreatment system for swine manure that should involved minimum handling by the farmer. A demonstration plant has been installed in the Paris region. The intensive lagooning system consists of algal ponds, daphnid ponds and a polishing fish pond working in series with a total area of 2100 m² and a total volume of 3600 m³.

The performance of the system was evaluated under winter conditions with raw decanted swine manure by measuring N-NH₄⁺ and P-PO₄³⁻ removal, pH, temperature, water oxygen, algal biomass and daphnid productions.

Results showed that low temperatures (<5°C) did not allow any significant biomass production (0·41–0·68 g dry mass/m² d). Ammonia-nitrogen, mostly stripped (98% lost by stripping), and phosphate removals were small. However, as soon as the temperature increased in spring (March), ammonia-nitrogen removal was improved with a large contribution (71%) due to stripping and the algal productivity increased to ≈ 3·5 g dry mass/m² d; CO₂ appeared to be a limiting factor.

Ammonia-nitrogen, nitrate, nitrite and orthophosphate showed marked variations that could be correlated with manure overdoses.     

Vinyl imidazole carrying metal-chelated beads for reversible use in yeast invertase adsorption

Poly(ethylene glycol dimethacrylate-n-vinyl imidazole) [poly(EGDMA–VIM)] hydrogel (average diameter 150–200 μm) was prepared copolymerizing ethylene glycol dimethacrylate (EGDMA) with n-vinyl imidazole (VIM). Poly(EGDMA–VIM) beads had a specific surface area of 59.8 m²/g. Poly(EGDMA–VIM) beads were characterized by swelling studies and scanning electron microscope (SEM). Cu²⁺ ions were chelated on the poly(EGDMA–VIM) beads (452 μmol Cu²⁺/g), then the metal-chelated beads were used in the adsorption of yeast invertase in a batch system. The maximum invertase adsorption capacity of the poly(EGDMA–VIM)–Cu²⁺ beads was observed as 35.2 mg/g at pH 4.5. The adsorption isotherm of the poly(EGDMA–VIM)–Cu²⁺ beads can be well fitted to the Langmuir model. Adsorption kinetics data were tested using pseudo-first- and -second-order models. Kinetic studies showed that the adsorption followed a pseudo-second-order reaction. The value of the Michaelis constant K_m of invertase was significantly larger upon adsorption, indicating decreased affinity by the enzyme for its substrate, whereas V_max was smaller for the adsorbed invertase. The optimum temperature for the adsorbed preparation of poly(EGDMA–VIM)–Cu²⁺-invertase at 50 °C, 10 °C higher than that of the free enzyme at 40 °C. Storage stability was found to increase with adsorption. Adsorbed invertase retains an activity of 82% after 10 batch successive reactions, demonstrating the usefulness of the enzyme-loaded beads in biocatalytic applications.     

Effect of clomiphene on Ca movement in human prostate cancer cells

The effect of clomiphene, an ovulation-inducing agent, on cytosolic free Ca²⁺ levels ([Ca²⁺]_i) in populations of PC3 human prostate cancer cells was explored by using fura-2 as a Ca²⁺ indicator. Clomiphene at concentrations between 10-50 μM increased [Ca²⁺]_i in a concentration-dependent manner. The [Ca²⁺]_i signal was biphasic with an initial rise and a slow decay. Ca²⁺ removal inhibited the Ca²⁺ signal by 41%. Adding 3 mM Ca²⁺ increased [Ca²⁺]_i in cells pretreated with clomiphene in Ca²⁺-free medium, confirming that clomiphene induced Ca²⁺ entry. In Ca²⁺-free medium, pretreatment with 50 μM brefeldin A (to permeabilize the Golgi complex), 1 μM thapsigargin (to inhibit the endoplasmic reticulum Ca²⁺ pump), and 2 μM carbonylcyanide m-chlorophenylhydrazone (to uncouple mitochondria) inhibited 25% of 50 μM clomiphene-induced store Ca²⁺ release. Conversely, pretreatment with 50 μM clomiphene in Ca²⁺-free medium abolished the [Ca²⁺]_i increase induced by brefeldin A, thapsigargin or carbonylcyanide m-chlorophenylhydrazone. The 50 μM clomiphene-induced Ca²⁺release was unaltered by inhibiting phospholipase C with 2 μM 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122). Trypan blue exclusion assay suggested that incubation with clomiphene (50 μM) for 2-15 min induced time-dependent decrease in cell viability by 10-50%. Collectively, the results suggest that clomiphene induced [Ca²⁺]_i increases in PC3 cells by releasing store Ca²⁺ from multiple stores in an phospholipase C-independent manner, and by activating Ca²⁺ influx; and clomiphene was of mild cytotoxicity.     

In vivo manipulation of human breast cancer growth by estrogens and growth hormone: Kinetic and clinical results

Since 1983, a series of experimental and clinical studies have been carried out on the possibility of enhancing the chemotherapy effectiveness in breast cancer by expanding the fraction of cycling cells. Theoretically estrogens should recruit breast cancer cells and this fact should result in a higher killing efficiency of antiproliferative drugs. Actually it has been clearly shown, by means of the thymidine labeling index and primer-dependent -DNA polymerase assay, that low doses of diethylstilbesterol are able to increase the tumor proliferative activity of human breast cancer in vivo (estrogenic recruitment).

Three randomized trials have been carried out (one in locally advanced and two in metastatic breast cancer) comparing conventional polichemotherapy vs chemotherapy with estrogenic recruitment. Only limited advantages have been observed in these trials.

Searching for new modalities of kinetic manipulation of tumors, recombinant human growth hormone has been employed in a pilot study: the preliminary results indicate that it largely enhances tumor proliferative activity, suggesting the possibility of employing a growth factor system to increase chemosensitivity.     

Pb2+胁迫对绿球藻(Chlorococcum sp.)的影响研究

研究了不同Pb²⁺浓度(0.1、1、10、50、100、200、400 mg/L)处理对绿球藻(Chlorococcum sp.)生长、形态结构及生理特性的影响。与对照BG11培养的绿球藻比较,Pb²⁺浓度≤50 mg/L条件下培养的绿球藻细胞壁无明显增厚,色素变化不大;而暴露到Pb²⁺浓度>50 mg/L条件下培养,绿球藻细胞壁明显增厚,蛋白核消失。低浓度Pb²⁺(0.1~10 mg/L)对绿球藻生长基本没有影响;浓度在50 mg/L时,绿球藻仍能维持一定的生长速率;但当Pb²⁺浓度≥100 mg/L时,绿球藻的生长受到显著抑制。绿球藻的Chl a+Chl b以及Chl a含量均随培养基中Pb²⁺浓度的升高而逐渐减少。绿球藻净光合作用强度随培养基中Pb²⁺浓度的增大而逐渐降低,Pb²⁺浓度≥100 mg/L时净光合作用强度检测不到;当Pb²⁺浓度<50 mg/L时,绿球藻呼吸作用强度逐渐升高,之后呼吸作用强度逐渐降低。在实验的浓度下,绿球藻的丙二醛(MDA)含量、超氧化物歧化酶(SOD)和过氧化物酶(POD)活性都随培养基中Pb²⁺浓度的升高而逐渐增强;过氧化氢酶(CAT)则随Pb²⁺浓度的增大酶活性先升高后降低。当Pb²⁺浓度≤100 mg/L时,绿球藻对Pb²⁺的去除率都在95%以上;之后逐渐降低,浓度到400 mg/L时仍然达56.7%。结果显示,绿球藻是一种耐受Pb²⁺胁迫的藻类,对铅的去除率也高,可以应用于含铅污水的处理。     

Neuroprotective Effect of the Iron Chelator Desferrioxamine Against MPP+ Toxicity on Striatal Dopaminergic Terminals

Abstract: Microdialysis was used to evaluate the effect of desferrioxamine (DES) against 1-methyl-4-phenylpyridinium (MPP⁺) toxicity. The presence of DES (40 fmol-40 nmol/15 min for a total of 90 min) in the Ringer solution, coperfused with MPP⁺ (40 nmol/15 min) on day 1, produced on day 2 a higher extracellular dopamine output after perfusion of MPP⁺ than in control MPP⁺ perfusion experiments, in which no DES was administered on day 1. Both Ringer perfusion alone (control Ringer) and coperfusion of 40 nmol DES with 40 nmol MPP⁺ on day 1 produced on day 2 similar increases in extracellular dopamine output after a second MPP⁺ perfusion. In the control Ringer experiment, note that the MPP⁺ on day 2 is the first MPP⁺ perfusion. Perfusion of 800 fmol FeCl₃/15 min along with 40 nmol MPP⁺ and 400 fmol DES on day 1 completely abolished on day 2 the neuroprotective effect found with 40 nmol MPP⁺ and 400 fmol DES; 800 fmol FeCl₃ did not increase the neurotoxic effect of 40 nmol MPP⁺ perfusion. The ability of DES to protect against MPP⁺ toxicity may indicate a therapeutic strategy in the treatment of diseases when iron is implicated.     

In vitro analysis of intestinal absorption of cadmium and calcium in rainbow trout fed with calcium- and cadmium-supplemented diets

The protective effects of dietary Ca²⁺ supplementation against Cd accumulation in rainbow trout Oncorhynchus mykiss fed with Cd-contaminated food were evaluated in relation to chronic changes in intestinal absorption rates. The changes were measured ' in vitro '. The control diet contained c. 20 mg Ca²⁺ g⁻¹ food and 0·25 μg Cd g⁻¹ food; the experimental diets were supplemented with CaCO₃ and Cd(NO₃)₂·4H₂O to levels of 50 mg Ca²⁺ g⁻¹ food and 300 μg Cd g⁻¹ food, alone and in combination. The Ca²⁺ and Cd absorption rates were measured using radiotracers (⁴⁵Ca, ¹⁰⁹Cd) at total Ca²⁺ and Cd concentrations of 3·0 and 0·12 mmol l⁻¹, respectively in the intestinal saline. Chronically elevated dietary Cd caused a significant increase in Cd absorption rate by up to 10-fold at 30 days in the mid-intestine. The high Ca²⁺ diet prevented this up-regulation of Cd transport rate. Conversely, intestinal Ca²⁺ absorption was significantly increased by two- to five-fold by the Ca²⁺-supplemented diet at 30 days in both the mid- and posterior intestine, and this effect was eliminated when Cd was simultaneously elevated in the diet. Ca²⁺ and Cd probably interact at common pathways and transport mechanisms in the intestine, though independent pathways may also exist.     

血毒清联合杂合肾脏替代治疗对重症脓毒症的疗效、血流动力学和预后干预作用的研究

目的探讨血毒清联合杂合肾脏替代治疗（HRRT）重症脓毒症的效果及对血流动力学、预后的影响。 方法选取2017年3月至2019年8月十堰市太和医院重症脓毒症患者135例,在常规治疗基础上,按简单随机化法分为血毒清组、HHRT组和血毒清联合HRRT组（联合组）,每组45例,治疗5 d。治疗前和治疗5 d后序贯器官衰竭评分（SOFA）、急性生理学与慢性健康状况评分系统Ⅱ评分（APACHEⅡ）、炎症因子指标[白细胞介素-10（IL-10）、IL-6、降钙素原（PCT）、C反应蛋白（CRP）]水平、血流动力学指标[全身血管阻力指数（SVRI）、血管外肺水指数（EVLWI）、胸腔内血容积指数（ITBVI）、心指数（CI）]及重症监护室（ICU）住院时间比较采用配对t检验,多组间差异采用方差分析,组间两两比较采用LSD-t检验,3组28 d病死率采用c²检验。 结果治疗5 d后,与联合组比较,HHRT组和血毒清组SOFA评分[（4.29±1.17）分比（6.15±1.39）分、（7.03±1.52）分]、APACHEⅡ评分[（11.68±2.12）分比（14.26±3.04）分、（15.17±2.85）分]、血清IL-10 [（36.61±6.50）μg/L比（42.75±7.42） μg/ L、（45.06±8.37） μg / L]、IL-6 [（130.26±41.04） pg/ mL比（169.84±46.75） pg/ mL、（178.36±50.91） pg/ mL]、PCT [（0.87±0.29） ng/mL比（1.96±0.47） ng/mL、（2.24±0.53）ng/mL]、CRP [（34.93±9.71） mg/ L比（51.67±10.32）mg/L、（56.79±11.82）mg/L] 、EVLWI [（4.12±1.38）mL/kg比（5.38±1.69） mL/ kg、（6.04±1.85）mL/kg]降低,而SVRI [（2079.54±124.75） dyn·s·cm^{- 5}·m²比（1865.37±109.38） dyn·s·cm^-5·m²、（1796.28±131.75）dyn·s·cm^-5·m²]、ITBVI [（1189.40±92.36） mL/ m²比（986.97±75.32）mL/m²、（902.37±68.64） mL/ m²]、CI [（4.26±0.65） L·min^-1·m^-2比（3.83±0.58）L·min^-1·m^-2、（3.67±0.53）L·min^-1·m^-2]均升高,差异均有统计学意义（P < 0.05）。与联合组比较,HHRT组和血毒清组ICU住院时间[（14.82±4.40）d比（17.20±3.47）d、（18.46±4.25）d]缩短（P < 0.05）。 结论血毒清联合HRRT治疗重症脓毒症,对减少炎性因子水平,调节血流动力学具有一定作用,能够缩短ICU住院时间。     

秋冬季叶施N、Fe提高假俭草草坪抗寒性研究

在过渡性气候地区的假俭草草坪,宜在最低气温为12℃时(11月中、下旬)叶施Fe,最佳施用浓度为:单施Fe为0.6L/m²,N+Fe为4g/m² N+0.6L/m²Fe。秋冬季叶施Fe、N+Fe可提高草体内抗寒指标性物质的含量,叶施0.6L/m² Fe或4g/m² N+0.6L/m² Fe,可使草坪草体内脯氨酸、可溶性糖类含量及过氧化氢酶的活性分别提高25%、310%、180%和41%、182%、160%。叶施N+Fe处理的效果比单独施Fe的效果更好,施后草坪枯黄期比对照组推迟6~8d,半致死温度降低3~4℃。     

Quantification of some active compounds in air samples at pharmaceutical workplaces by HPLC

Workers involved in the manufacture of drug substances may be exposed to active pharmaceuticals by inhalation of drug dusts or droplets which has been considered the main exposure route. The proposed HPLC method allowed to determine sulpiryde, hydroxyurea and dyprophylline in the concentration range of 0.01–0.187 mg/m³, 0.001–0.08 mg/m³ and 0.01–0.40 mg/m³ for sulpiryde, hydroxyurea and dyprophylline, respectively, when 480 L of air sample was collected on the glass fibre filters. Sulpiryde was extracted with a solvent system consisting of acetonitrile–phosphate buffer at pH 3 (85:15, v/v), while the best efficiency of extraction for hydroxyurea and dyprophylline was achieved using water. HPLC analysis of sulpiryde with fluorescence detection was more sensitive (LOD = 3.1 μg/L) in comparison with UV detection (LOD = 84.4 μg/L).     

宁波港典型海域浮游动物种类组成及数量分布特点

根据2009年秋～2010年夏每季采样调查,分析和研究了浙江省宁波港海区浮游动物种类组成和数量分布的四季变化特征。结果表明: 经鉴定浮游动物共有70种,隶属3门35属。其中桡足类的种类最多,占总种数的73.54%; 优势种主要有中华异水蚤、矩形龟甲轮虫、伪长腹剑水蚤、挪威小星猛水蚤、小星猛水蚤属、驼背隆哲水蚤、短角长腹剑水蚤等。浮游动物群体丰度呈现出夏季>秋季>春季>冬季的现象,四季平均丰度分别为2.50×10³ ind/m³、40.16×10³ ind/m³、3.72×10³ ind/m³、1.20×10³ ind /m³。生物量呈现出夏季>春季>秋季>冬季的现象,四季平均生物量分别为88.94 mg/m³、931.22 mg/m³、58.74 mg/m³、24.49 mg/m³。与历史资料以及邻近海域比较发现,浮游动物丰度和生物量小于或接近于东海各海域。生物多样性分析显示,夏季与春秋冬三季生物多样性(H')有显著性差异(P<0.05),夏季具有较高的生物多样性,Shannon-Wiener多样性指数(H')、种类丰富度(D)、Pielou均匀度指数(J)、最大多样性指数(H'max)基本呈现出夏季>春季>秋季>冬季。与邻近海域相比,多样性指数(H')、种类丰富度(D)、最大多样性指数(H'max)呈下降趋势。